Gerard Ber - 10 Jun 2021 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Director
Signature
/s/ Gerard Ber
Issuer symbol
YMAB
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
14 Jun 2021, 17:03:48 UTC
Previous filing
12 May 2021
Next filing
12 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Non-Employee Stock Option (right to buy) Award $0 +16,000 $0.000000 16,000 10 Jun 2021 Common stock 16,000 $37.53 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
F2 The stock options vest in equal monthly installments during the first year following the date of grant, subject to the Reporting Person's continued service on the board of directors of Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting.